SURGY vs ARCLK Comparison
Price, market cap, valuation, profitability and leverage metrics of SURGY and ARCLK side by side.
If you had invested TRY 10,000
Metric comparison
| Metric | SURGY | ARCLK | Sector median |
|---|---|---|---|
| Last price (TL) | 20.78 | 85.15 | 6.84 |
| Daily change | −4.59% | −0.76% | −3.40% |
| Market cap | TRY 3.5B | TRY 57.5B | TRY 5.6B |
| P/B | 0.34 | 0.75 | 0.45 |
| Dividend yield | — | 1.71% | 1.34% |
| Return on equity | −8.06% | −4.06% | 0.92% |
| Free float | 29.70% | 17.46% | 28.00% |
Popular comparisons
Related pages
About the SURGY vs ARCLK comparison
Price, market cap, valuation multiples, profitability and leverage of SURGY (Sur Tatil Evleri GMYO) and ARCLK (Arçelik) side by side as of Sep 28, 2026, 11:41. Of the 11 metrics compared, SURGY leads in 5 and ARCLK leads in 6.
Highlights: Daily change: ARCLK leads (−0.76% vs −4.59%). Market cap: ARCLK leads (TRY 57.5B vs TRY 3.5B). P/B: SURGY leads (0.34 vs 0.75). EV/Sales: ARCLK leads (0.90 vs 204.54). Gross margin: SURGY leads (47.03% vs 29.57%). EBITDA margin (annual): SURGY leads (2,129.73% vs 14.15%). Net margin (annual): ARCLK leads (−0.60% vs −1,274.66%). Return on assets: ARCLK leads (−0.53% vs −5.70%).
Frequently asked questions
Is SURGY or ARCLK cheaper?
By P/E, Tie is cheaper (— vs —); by P/B, SURGY trades at the lower multiple (0.34 vs 0.75).
Which is more profitable, SURGY or ARCLK?
Annual net margin is −1,274.66% for SURGY and −0.60% for ARCLK; return on equity is −8.06% for SURGY and −4.06% for ARCLK.
Which is more leveraged, SURGY or ARCLK?
The leverage ratio is 30.27 for SURGY and 86.30 for ARCLK; net debt/EBITDA is — for SURGY and 2.78 for ARCLK. Lower values mean less leverage.
Where does the comparison data come from?
Prices and market caps come from 15-minute delayed Borsa Istanbul data; ratios are calculated from the latest financial statements filed with KAP. Some ratios are not defined for banks and insurers.